The Analysis of Residual Solvents By Headspace Sampling and GC According to USP <467>

Importance of the Topic

Residual solvents are organic volatile impurities that remain in drug products after manufacturing and can impact safety, efficacy, and regulatory compliance. Analyzing these trace compounds is essential for pharmaceutical quality control and process optimization.

Objectives and Study Overview

This study evaluates the performance of a Bruker 450‐GC gas chromatograph coupled with an SHS‐40 headspace sampler for the determination of 26 USP <467> residual solvents. The aim is to verify linear calibration, assess method repeatability, and demonstrate compliance with pharmacopeial requirements.

Methodology and Instrumentation

• Sample Preparation: Stock solutions of 26 solvents (100–500 ppm) were diluted in deionized water to generate calibration standards and validation samples.
• Instrumentation Setup:
• Bruker SHS‐40 Headspace Sampler: Oven at 80 °C, valve and transfer lines at 180 °C, 60 min preconditioning with shaking, 45 min analysis time.
• Bruker 450‐GC Gas Chromatograph: BR‐624ms column (60 m × 0.32 mm, 1.8 µm), injector at 200 °C with 1:10 split, FID at 270 °C, He carrier gas at 1 mL/min, oven program starting at 40 °C for 20 min then ramping at 10 °C/min to 250 °C.
• Data handled using Compass CDS software.

Main Results and Discussion

Calibration curves for representative solvents such as pentane, benzene, dichloromethane, and n‐butanol showed excellent linearity (R2 ≥ 0.997). Across all 26 compounds, correlation coefficients ranged from 0.9766 to 0.9997, indicating a robust linear response. Repeatability tests at 100 ppm demonstrated relative standard deviations below 5% for selected solvents, confirming method precision.

Benefits and Practical Applications

• Full compliance with USP <467> requirements for residual solvent analysis.
• Wide applicability across different solvent safety classes and chemical polarities.
• High sensitivity and reproducibility suitable for routine QC in pharmaceutical and industrial laboratories.

Future Trends and Possibilities

• Use of salting‐out agents like sodium sulfate to further improve analyte partitioning and sensitivity.
• Automation of sample preparation and data processing to increase laboratory throughput.
• Extension of the method to emerging solvents in green chemistry and advanced pharmaceutical synthesis.

Conclusion

The combined Bruker 450‐GC and SHS‐40 system offers a reliable, linear, and repeatable method for residual solvent analysis according to USP <467>, supporting stringent quality control practices in pharmaceutical development and production.

Reference

1. Organic Volatile Impurities / Residual Solvents <467>, United States Pharmacopeia USP 32‐NF 18.